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Selective isotope labellingThe molecular chaperone Hsp90 plays a crucial role in folding and maturation of regulatory proteins. Key
aspects of Hsp90's molecular mechanism and its adenosine-5'-triphosphate (ATP)-controlled active cycle
remain elusive. In particular the role of conformational changes during the ATPase cycle and the molecular
basis of the interactions with substrate proteins are poorly understood. The dynamic nature of the Hsp90 ma-
chine designates nuclear magnetic resonance (NMR) spectroscopy as an attractive method to unravel both
the chaperoning mechanism and interaction with partner proteins. NMR is particularly suitable to provide
a dynamic picture of protein–protein interactions at atomic resolution. Hsp90 is rather a challenging protein
for NMR studies, due to its high molecular weight and its structural ﬂexibility. The recent technologic ad-
vances allowed overcoming many of the traditional obstacles. Here, we describe the different approaches
that allowed the investigation of Hsp90 using state-of-the-art NMR methods and the results that were
obtained. NMR spectroscopy contributed to understanding Hsp90's interaction with the co-chaperones
p23, Aha1 and Cdc37. A particular exciting prospect of NMR, however, is the analysis of Hsp90 interaction
with substrate proteins. Here, the ability of this method to contribute to the structural characterization of not
fully folded proteins becomes crucial. Especially the interaction of Hsp90 with one of its natural clients,
the tumour suppressor p53, has been intensively studied by NMR spectroscopy. This article is part of a Spe-
cial Issue entitled: Heat Shock Protein 90 (HSP90).
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Protein folding in the cell is organised by molecular chaperones
[1,2]. The major chaperone systems are ATP regulated machines
conserved from bacteria to man: Hsp60, Hsp70, Hsp90 and
Hsp100 [3]. The chaperone classes differ dramatically in sequence
and structure, which relates to different function. The Hsp90 family
is of particular interest because some of its members are especially
dedicated to signal transduction [4].
The number of Hsp90 homologues per cell correlates with com-
plexity of the organism [5]. Bacteria such as Escherichia coli have
only one homologue, HtpG, while yeast cells have one or two ho-
mologues in the cytosol and one inmitochondria, but none in the endo-
plasmic reticulum (ER). In human cells there are four Hsp90 isoforms:
the heat shock inducible Hsp90α and the constitutively expressed
Hsp90β both in the cytosol, mitochondrial Trap1 and Grp94 located
in the ER. Conservation within the family is high; the sequence ho-
mology between E. coli HtpG and human Hsp90s is around 50%.
Hsp90β is one of the most abundant proteins in the human cytosol,
it makes up 1–2% of cytosolic protein [6]. Hsp90 can suppress protein
aggregation in vitro, independent of ATP [7,8]. In vivo, however, ATPase
activity is essential for the Hsp90 working cycle hence cell viability.hock Protein 90 (HSP90).
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l rights reserved.Mutant Hsp90s with either faster or slower ATPase rate result in
temperature-sensitive growth phenotypes and they are unable to fully
activate their client proteins [9,10].
Hsp90 is a rather dynamic molecule and ATP hydrolysis is associ-
ated with conformational changes (Fig. 1). Those conformational
changes are conserved from bacteria to man [11] and most likely
linked to substrate interaction [12]. The functional role of Hsp90's
conformational dynamics, however, remains elusive [3].
A zoo of co-chaperones controls Hsp90's ATPase activity and con-
formational changes. The co-chaperones Cdc37 and p23 prevent ATP
hydrolysis while Aha1 stimulates it [13]. Several of Hsp90's substrate
classes require speciﬁc co-chaperones for recruitment of Hsp90. For
the progesterone and glucocorticoid receptors and the kinase Chk1
the minimal set of co-chaperones had been determined [14,15]. For
reconstitution of steroid binding activity in vitro, both steroid receptors
required an Hsp70 and its co-chaperone Hsp40 for initial complex for-
mation, Hop, which links Hsp70 and Hsp90, then Hsp90 itself and its
co-chaperone p23. Chk1 needs the same set of co-chaperones to be-
come active but it requires the kinase-speciﬁc co-chaperone Cdc37
instead of p23 [16]. The contribution of each co-chaperone to folding
and maturation of substrate proteins, however, is poorly understood.
NMR spectroscopy plays a key role in elucidating the mechanism
of the Hsp90 machine and its interactions with co-chaperones and
substrates. In this review, we will give a short overview of the key
questions that can be targeted by NMR, and the progress that was
already made using this technique.
Fig. 1. Hsp90 dimer exhibits different conformations. A, Structure of the closed confor-
mation of the yeast Hsp90 in complex with p23 and AMP-PNP [22]. B, Structure of the
extended Hsp90 homologue HtpG from bacteria [43].
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Hsp90 plays an important regulatory role for a limited but rather
diverse set of substrate client proteins, such as activation of kinases,
maturation of steroid receptors, and assisting in folding of e.g. the
tumour suppressor p53 or the cystic ﬁbrosis transmembrane conduc-
tance regulator (CFTR) [4]. The oncogenic nature of a signiﬁcant
fraction of its substrate pool made Hsp90 a target for anti-cancer
drugs [17]. Interestingly, Hsp90 also interacts with model proteins
such as luciferase and citrate synthase [7,18].
Hsp90 is believed to act at late folding stages [7], which may sug-
gest a similar structural motif present in all substrates. Such a motif,
however, never was found. This might be related to the fact that the
substrate proteins identiﬁed so far differ dramatically in sequence
and structure (an updated list of Hsp90 interactors is maintained at
http://www.picard.ch/downloads/Hsp90interactors.pdf). Interestingly,
while functional studies discovered mainly substrate proteins with
regulatory function, large-scale proteomics studies revealed more di-
versity. A study of the interactome of the yeast homologue described
627 putative Hsp90 substrates and co-factors, which represent ~10%
of the yeast proteome [19]. Such diversity in the substrate pool suggests
a ratherﬂexible substrate selection, possibly regulated by co-chaperones.
It should be pointed out, though, that the molecular understanding
of Hsp90's substrate recognition principles is still limited, and the
paradigms may change when more data become available. A crucial
bottleneck is the lack of detailed structural information on Hsp90–
substrate complexes.
3. Structural organisation of Hsp90
Hsp90 chaperones are homodimers consisting of three con-
served domains (Fig. 1). The N-terminal domain (Hsp90-N) contains
the ATP binding site [20]. The basal ATPase rate is rather low
(kcat=1.7×10−3 s−1, for human Hsp90β) and requires both
Arg391 of the catalytic loop of the middle domain and the transient
dimerization of the N-terminal domain [21,22]. Therefore, isolatedHsp90-N does not have signiﬁcant ATPase activity [23]. It is involved
in binding to several co-chaperones, including p23, Cdc37, Aha1
and Sgt-1 [13,24,25]. Substrate binding properties have also been
allocated to Hsp90-N [26–30].
The middle domain (Hsp90-M) is required for activating the ATP
hydrolysis in Hsp90-N and contributes to binding of p23 and Aha1
[13,22,31]. Hsp90-M was implied to be involved in binding of sub-
strates [29,30,32,33].
The C-terminal domain (Hsp90-C) is the dimerization domain. It
was suggested to contribute to substrate binding [27,28,34,35]. An
alternative ATP binding site in Hsp90-C is discussed [36,37], but
structural studies failed to identify a speciﬁc nucleotide-binding
pocket [22,34]. The C-terminus of the cytosolic eukaryotic homo-
logues has a MEEVD motif that is recognised by TPR domains of sev-
eral co-chaperones, some of which link the Hsp90 system to the
Hsp70 system (via the adaptor protein Hop) and the proteasome
(via the E2 ubiquitin ligase CHIP) [38–41].
While the three domains have a high degree of identity, the N- and
C-terminal extensions and the linkers connecting the domains differ
between homologues. Most notable is the charged, disordered linker
between Hsp90-N and Hsp90-M, which is around 80 residues long in
human Hsp90βwhich is almost missing in bacterial andmitochondri-
al homologues [42].
4. Hsp90 is a plastic molecule
In recent years several structural studies of Hsp90 provided con-
siderable progress to the mechanistic understanding of this chaper-
one machine. High-resolution X-ray structures of full-length Hsp90
were obtained for several homologues and several nucleotide states.
The structure of the yeast Hsp90 bound to the ATP analogue AMP-PNP
and to the co-chaperone p23 revealed a picture of the ATP-bound
state, while crystallographic studies of the HtpG revealed pictures of
the nucleotide-free and the ADP-bound state [22,43]. Those structures
demonstrate that Hsp90 can adopt different conformations triggered
by nucleotides. Interestingly, structures of the ER homologue Grp94 in
various nucleotide states failed to show similar nucleotide-dependent
changes as they were observed for the cytosolic counterparts [44]. At
present it is an open question to which extent the nucleotide state
alone is able to deﬁne speciﬁc conformational states in the absence of
co-chaperones, which are still to be discovered for Hsp90s in the ER
and the bacterial cytosol.
Structural studies employing X-ray crystallography, electron mi-
croscopy (EM) and small-angle X-ray scattering (SAXS) revealed
signiﬁcant structural ﬂexibility of Hsp90 and a species-dependent
equilibrium between conformations [11,13,45]. Surprisingly, recent
single molecule studies indicated that Hsp90's conformational
space contains dimers that are connected via their N-terminal
domains but open at the C-terminus [46]. At present the connection
between conformational plasticity and function is only poorly un-
derstood. The most promising way to proceed would be a compre-
hensive study of the same homologue in the different nucleotide
states in solution, as it is possible with NMR spectroscopy.
5. Hsp90 is a challenging molecule for NMR spectroscopy
The current state of the Hsp90's structural biology now allows
focussing on the dynamic nature of Hsp90's functional cycle. NMR
spectroscopy is particularly suitable to reveal a dynamic picture of
protein complexes in solution at atomic resolution [47]. One of the
advantages of NMR is the visualisation of the labelled component
only, e.g. Hsp90, a co-chaperone or a client protein. High-resolution
NMR spectra allowmapping of both interaction surfaces and conforma-
tional changes in a protein structure upon binding of partner proteins.
This dual ability makes NMR spectroscopy a powerful research tool to
address biochemical research questions. At times it can be a challenge,
Table 1
Assignments of Hsp90 and Hsp90 domains.
Species Protein Assignments Reference
Yeast Hsp90-N 95% of backbone 1H, 15N
and 13C
BMRB: 5355 (Salek et al.) [50]
Human Hsp90-N 82% of backbone 1H, 15N
and 13C
BMRB: 7003 (Jakobs et al.,
2006) [103]
Yeast Hsp90-M 85% of backbone 1H, 15N
and 13C
BMRB: 16279 (Hagn et al.) [35]
Human Hsp90-M backbone 1H, 15N and 13C (Park et al.) [71]
Yeast Hsp90‐C 85% of backbone 1H, 15N
and 13C
(Hagn et al.) [35]
Human full length Isoleucine δ-methyl groups (Park et al.) [71]
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experiments such as cross-saturation transfer and hydrogen-deuterium
exchange studies or additional biochemical work such as introducing
speciﬁc mutants dissolve such ambiguities.
The high molecular weight (around 170 kDa for human cytosolic
Hsp90 dimer) and its dynamic nature make the full length Hsp90 a
rather challenging subject for NMR spectroscopy. Protein NMR
studies usually require uniform 15N labelling and well-resolved
2D 1H–15N correlation spectra. The traditional protein size limit
for high-resolution 1H–15N NMR spectroscopy, however, is around
30 kDa for typical globular proteins [47]. This makes the isolated
domains of Hsp90 accessible for such methods.Hsp90α partially assigned
Human full length
Hsp90β
18 out of 48 isoleucines
δ-methyl groups
BMRB: 17933 (Karagöz
et al.) [63]6. High resolution studies of Hsp90 domains
The shape of the individual domains in isolation and within the
context of the full-length protein is rather similar [22, 43]. Structural
studies of the separate domains can, therefore, be meaningful, even
though they do not allow conclusions on the interdomain dynamics.
Detailed structural data on domains are useful for protein–protein/
ligand interaction studies to identify local perturbations.
The N-terminal domain is the part of Hsp90 that is best charac-
terised by NMR spectroscopy [48–50]. It is a stable and well-folded
25 kDa protein that has excellent spectroscopic properties (Fig. 2).
The assignment of Hsp90-N is of particular interest since it is the ATP-
binding domain and the target for inhibitors blocking its nucleotide-
binding site.
The ﬁrst 1H–15N spectra of the middle domain of Hsp90 became
available for the chicken homologue of Hsp90α, along with Hsp90-
NM and -MC constructs (Table 1) [51]. The spread of signals in the
1H–15N spectra indicates that the protein is well folded and has only
a few unstructured regions. The spectra of Hsp90-M of the human
homologue Hsp90β are also well resolved (Fig. 3). 1H–15N correlation
spectra of the middle domain for both Hsp90 homologues are rather
similar, with small differences probably derived from minor distinc-
tions in conformations, e.g. of loops between helices, and variability
of experimental conditions. The protein behaves well in solution,
although it tends to aggregate at concentrations higher than 500 μM
(Rüdiger group, unpublished).
Hsp90-C is more difﬁcult to assess by NMR spectroscopy. The size
of the Hsp90-C dimer, 37 kDa for human Hsp90β, is suitable for NMR
experiments. However, ﬂexible regions and aggregation at NMR con-
centrations render high-resolution analysis of human Hsp90-C more
complex than for the other Hsp90 domains (Rüdiger group, unpub-
lished). A dimeric construct of yeast Hsp90-C (529–689), however,
shows good spectroscopic properties and is partially assigned (Table 1)
[35].12 10 8 6
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Fig. 2. 1H–15N HSQC NMR spectroscopy spectra reveal excellent spectroscopic proper-
ties of the N-terminal domain of human Hsp90β.The most attractive application of NMR spectroscopy to isolated
domains of Hsp90 is the analysis of anti-cancer drug binding. Hsp90
is an attractive target for drug design since it assists in the proper
folding of signal transduction proteins [17,52]. Such Hsp90 substrates
as p53, Cdk4, c-Src/v-Src, and HER-2/HER-3 are oncogenic. There are
several approaches for inhibitors design: strong binding to ATP-
binding pocket at the N-terminal domain (geldanamycin, radicicol),
targeting a putative ATP-binding site in the C-terminal domain
(novobiocin) and blocking interaction with co-chaperones (celas-
trol) [17,53,54]. Inhibitors currently undergoing clinical trials all
target the N-terminal domain. The putative C-terminal nucleotide-
binding site was neither found in any of the crystal structures of various
Hsp90 homologues nor in NMR experiments of full length Hsp90
[22,34,44,55]. Nucleotides and such inhibitors as geldanamycin and
radicicol bind to the same binding pocket in the N-terminal domain.
An NMR analysis showed that ATP and ADP interact with Hsp90-N in
the same manner with only small differences [49]. The drugs geldana-
mycin and radicicol induce additional ligand-speciﬁc perturbations
therefore may affect the overall conformation of the Hsp90-N [49]. In
general, effective drug design proﬁts from the combination of the
high-resolution crystal structures and NMR experiments, which give
insights into the dynamics of the Hsp90–ligand complexes.
7. Full-length Hsp90 studied by NMR
The synergistic interaction of the domains within the Hsp90 dimer
requires analysis of the full-length molecule to understand the con-
formational changes throughout its active cycle. This is particularly
highlighted by the fact that the isolated N-terminal domain does
not show any dimeric interaction in solution both in the presence
and absence of ATP [20,26]. The Hsp90 full-length protein, however,
requires more sophisticated NMR experiments than those described12 10 8 6
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110
Hsp90-M
15N(ppm)
1H(ppm)
Fig. 3. 1H–15N HSQC NMR spectroscopy spectra show that the middle domain of human
Hsp90β is well folded.
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Fig. 4. CRINEPT–TROSY NMR spectroscopy allows studying of the backbone of full-
length Hsp90. The perdeuterated 170 kDa Hsp90 dimer was measured using 1H–15N
CRINEPT–TROSY pulse sequences [62]. The inset is a magniﬁcation of signals in the
β-sheet region.
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lecular weight and the presence of disordered regions.
7.1. NMR of backbone amides of full length Hsp90
The molecular weight of 170 kDa of the Hsp90 dimer leads to slow
tumbling in solution. This results in a loss of spectral sensitivity of
large proteins due to an effect called transverse relaxation [56]. In a
two-dimensional heteronuclear NMR experiment proton magnetiza-
tion is created as a ﬁrst step. Then it is transferred to either 15N or
13C nuclei via polarisation transfer step. The magnetisation evolves
there for a time period called “evolution” and acquires a frequency
label speciﬁc for the nuclei it was transferred to. After the frequency
labelling step the magnetisation is transferred back to proton via
reverse polarisation step and there it is detected during the acquisi-
tion period. Transverse relaxation occurs both during polarisation
transfer steps and frequency labelling periods leading to signal loss
and line broadening of spectra.
The development of novel NMR techniques by the Wüthrich lab-
oratory allowed overcoming size obstacles [57]. In particular the
combination of TROSY (transverse relaxation optimised spectros-
copy) and CRINEPT (cross-relaxation enhanced polarisation transfer)
techniques made full-length Hsp90 accessible for NMR spectroscopy.
TROSY extends NMR spectroscopy to up to 100 kDa by suppressing
transverse relaxation during evolution and acquisition periods, there-
fore reducing signal loss and line broadening [57,58]. A successful
application of TROSY techniques in the chaperone ﬁeld is the work
or the Zuiderweg group on allostery of Hsp70 [59,60]. CRINEPT
extends the effect of TROSY to heteronuclear polarisation transfer
periods. It provides a signiﬁcant gain in sensitivity for big protein
complexes of 150 kDa and larger in comparison to the commonly
used polarisation transfer techniques like INEPT [57]. The combina-
tion of TROSY with CRINEPT makes even the 900 kDa GroEL-GroES
complex accessible for NMR experiments [61].
Another cause of sensitivity loss that is especially pronounced for
high molecular weight proteins is dipole-dipole relaxation. Dipole-
dipole relaxation of spin magnetization is not affected by TROSY and
CRINEPT. It occurs due to magnetic properties of protons: 1H as the
nucleus with highest magnetic dipole moment is the most effective
for causing this type of relaxation. In practice, dipolar interaction
occurs between observed 1H with remote protons and leads to signal
loss. The exchange of those protons to deuterium overcomes this
problem and decreases relaxation. Deuterium has a considerably
lower magnetic dipole moment than protons. It is possible to keep
the protons of backbone amides or methyl groups protonated and
therefore NMR visible while deuterating the rest of the protein [56].
The application of CRINEPT–TROSY to perdeuterated 15N-labelled
full length Hsp90 results in a complex spectra of the backbone amides
(Fig. 4) [62]. The CRINEPT–TROSY spectra of Hsp90 show the typical
distribution of signals in the 1H dimension that is typical for folded
proteins, including signals in the region typical for β-sheet secondary
structure between 8.5 and 10 ppm in the 1H dimension. Most of those
signals are not visible when TROSY is used without CRINEPT [62]. The
most intensive signals in the spectra are, however, localised to the
random coil region. Those signals appear with doublets separated
by 90 Hz in both the 1H and the 15N dimension. It is a potential disad-
vantage of CRINEPT–TROSY pulse sequences that for highly dynamic
regions an additional set of signals is retained. The presence of
those signals next to signals corresponding to rigid parts of the mole-
cule indicates a signiﬁcant content of ﬂexible regions in Hsp90. A
comparison with spectra of the isolated domains revealed that most
of those signals represent the C-terminal domain (Rüdiger group,
unpublished).
While the CRINEPT–TROSY technique allows studying the back-
bone of full-length Hsp90, the complexity of the spectra makes peak
assignment difﬁcult. This limits the resolution at which interactionswith partners such as drugs, co-chaperones and substrate proteins
can be studied. The combination of CRINEPT–TROSY with protein
engineering techniques such as segmental isotope labelling might
be used in the future to reduce the spectral complexity of full length
Hsp90 [63].
Independent from the relaxation problems, large proteins such as
Hsp90 also face challenges that result from the shear number of resi-
dues. The interpretation of NMR experiments of large proteins
becomes increasingly complex when they contain a large number of
disordered and highly dynamic parts. Hsp90 owns long disordered
stretches in the N- and C-termini and in the inter-domain linkers,
which together account for more than 120 amino acids for human
Hsp90β. In principle, those stretches lead to comparable sharp and
intensive peaks. Their signal is enhanced due to the fast intrinsic
dynamics, while for the rigid parts signal strength is determined by
the tumbling of the molecule. However, the lack of a stable fold in
the linkers and terminal stretches limits differentiation of chemical
shifts for those stretches on the proton scale. This results in signiﬁcant
signal overlap in the random coil region of Hsp90's spectra (8.0–8.5 ppm
in the proton dimension; Fig. 4). Hsp90 is, therefore, a particularly
attractive target for techniques that limit complexity in NMR spectra.
7.2. High resolution spectra of full-length Hsp90 using side chain
labelling
Selective isotope labelling of a deﬁned subset of side chains is an
effective way to reduce spectral complexity [64]. It decreases the
total number of signals and, therefore, results in spectra with better
resolution. This makes it easier to assign signals and interpret results.
Most importantly, certain side chains result in higher signal intensity
compared to backbone amides. The hydrophobic amino acids Ile, Leu
and Val contain methyl groups that are rotationally not restricted,
resulting in intensive signals. Methyl-groups are the very attractive
targets for selective labelling not only because of their good spectro-
scopic properties but also because of effective labelling techniques
[65,66].
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precursors to selectively label the methyl groups Ile, Leu, and Val
[67]. Highly deuterated samples that are 1H–13C labelled at selective
methyl positions result in intense and well-dispersed 1H–13C corre-
lation spectra even for large structures such as the 20S proteasome
and the SecA translocation pore [68–70]. Recently the approach
was successfully applied ﬁrst to human Hsp90β and later also to
Hsp90α [55, 71].
Human Hsp90β contains 48 Ile side chains, which are well dis-
persed throughout the Hsp90 structure and present in every crucial
region (Fig. 5A). Twenty of them reside in the N-terminal domain.
The N-terminal domain is of particular interest due to its binding
to nucleotides and inhibitors and its transient dimerisation in the
ATP cycle. This makes Ile side chains rather attractive targets for
selective labelling strategies. All δ-methyl groups of Ile side-chains
can be speciﬁcally 1H and 13C labelled in an otherwise deuterated
human Hsp90β [55].
The Ile-labelled Hsp90 has excellent properties for methyl-TROSY
experiments (Fig. 5B) [55]. The spectra indicate the presence of rigid
next to dynamic segments, resulting in signiﬁcant variation of the
relative intensity and line width. This is consistent with similar ﬁnd-
ings for the amide backbone in CRINEPT–TROSY experiments [62].
Remarkably, 45 peaks appear in the spectra, which indicate that the
approach is sufﬁciently sensitive to monitor most of 48 possible Ile
side chains (Fig. 5B). Hsp90 behaves similar to the sum of its indi-
vidual domains. The comparison with spectra of the isolated Hsp90-
N, -M and -C constructs allowed annotation of the signals to one of
the domains [55,72]. Assignments of Hsp90-N and Hsp90-M can be
transferred to the full-length protein and allow high-resolution NMR
studies of the entire protein (Fig. 5C). Despite some signal overlap 12A
C
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B
13C(ppm)
Fig. 5. Isoleucines can be used as NMR markers for full-length Hsp90β. A, Homology model o
depicted as orange spheres. B, 1H-13C-Ile methyl-TROSY spectrum of full-length Hsp90. C, M
spectra of individual domains. Overlay of full-length Hsp90β 1H-13C-Ile methyl-TROSY spec
Hsp90-M, green; Hsp90-C, blue), homology structure of Human Hsp90β (Hsp90-M, green;
such as Lego bricks to generate an assignment for the full-length protein [55].Iles are assigned in Hsp90-N and 5 Iles in Hsp90-M (Table 1). Those
assignments provide a basis to study Hsp90's interaction with co-
factors, ligands and substrates.
Recently, Ile-speciﬁc labelling succeeded for Hsp90α, too [71].
The 1H–13C spectra of Hsp90β and Hsp90α show a good correlation
in pattern though with distinct differences that may be caused by
slightly different structural organisation of the isoforms. In the
Hsp90α study the ﬂexible linker between Hsp90-N and Hsp90-M
had been omitted to improve spectra. Good correlation between
spectra of Hsp90β full length and Hsp90α with deleted linker indi-
cates that the linker does not result in signiﬁcant structural changes.
Nevertheless, it cannot be excluded that removal of the linker might
have caused the minor discrepancies in the spectra of both Hsp90
homologues. Future NMR experiments comparing Hsp90α and
Hsp90β under identical conditions in solution may shed a light on
possible differences between both homologues.
In addition to NMR methods that provide high-resolution struc-
tural information and therefore mostly deal with local perturbation
it is also possible to monitor the overall hydrodynamic behaviour of
Hsp90 by NMR. Diffusion Ordered NMR spectroscopy (DOSY) allows
to determine a translation diffusion coefﬁcient which is a function
of protein size and shape [73]. For Hsp90 where conformational
ﬂexibility is crucial for function the diffusion studies provide impor-
tant information on structural changes upon interaction with ligands.
The translational diffusion coefﬁcient is determined by monitoring
the decrease in peaks intensity upon increasing the pulsed gradient
strength or diffusion time. Therefore the combination of DOSY with
selective 1H–13C labelling of methyl groups (3D DOSY–TROSY) is
particularly suitable for high molecular weight proteins and results
in precise determination of the translation diffusion coefﬁcient10
12
14
16
0.40.60.81.0
1H(ppm)
Full length Hsp90
13C(ppm)
f human Hsp90βwith both monomers in dark and light grey. Isoleucine methyl groups
ethyl groups of individual Ile residues were assigned via the 1H-13C-Ile methyl-TROSY
trum with spectra of the individual domains (full-length Hsp90β, black; Hsp90-N, red;
Hsp90-C, blue). The spectra of the individual domains can be put on top of each other
Fig. 6. The Aha1 binding site in Hsp90 maps to the N-terminal and middle domains.
Residues that shift upon interaction with Aha1-N and Aha1-C are depicted in red
(Hsp90-N and Hsp90-M, grey; Hsp90-C, blue) [82].
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for the ATP and ADP states of Hsp90 (TD and SGDR, unpublished).
8. Hsp90 co-chaperones: binding sites and stoichiometry
The activity of eukaryotic cytosolic Hsp90s is controlled by co-
chaperones regulating ATP hydrolysis, conformation, dynamics and
substrate binding and activation [75]. Insights into Hsp90's complexes
with co-chaperones allow conclusions on the individual steps of its
working cycle. Genetic studies on ten distinct Hsp90 co-chaperones
in different eukaryotic species showed that the presence of co-
chaperones is species dependent [5]. For example, the most dispersed
co-chaperone is Hop/Sti1, while the kinase-speciﬁc co-chaperone
Cdc37 presents only in nine out of 19 species. This divergence is con-
trasting the conserved nature of Hsp90 itself. It suggests that regulation
by co-chaperones could be adapted to speciﬁc substrate requirements.
Co-chaperone binding to Hsp90 regulates its conformation state.
p23 stabilises the closed state of Hsp90, while in contrast Hop/Sti1
and Cdc37/p50 prevent the N-terminal closing [22,76–78]. Since
Hsp90 is rather ﬂexible even upon interaction with nucleotides, co-
chaperones may stabilise the individual steps in the ATPase cycle.
Solution NMR studies thus may shed a light on the mechanism of
Hsp90's interaction with Aha1, Cdc37 and p23.
8.1. Mapping of the Aha1 binding site by NMR
Aha1 is the only one known ATPase activator among Hsp90 co-
chaperones [31,79]. Aha1 is involved in a vast set of cellular process-
es. It is involved in the activation of v-Src, glucocorticoid receptors
and regulates the quality control of CFTR [79,80]. The stability of
mutant CFTR is speciﬁcally enhanced in the absence of Aha1 [81]. The
crystal structure of Hsp90-M of the yeast homologue in complex with
the N-terminal domain of Aha1 disclosed the interaction surface and
indicates the mechanism of Hsp90 activation [31]. So far it was not
possible to solve a crystal structure of a complex of Aha1with full length
Hsp90.
Insights into the mechanism of the ATPase activation of Hsp90 by
Aha1 came fromNMR studies of domain complexes of Hsp90 and Aha1
[82,83]. Monitoring of hydrogen to deuterium exchange of 15N-labelled
Aha1 in the presence and absence of Hsp90-M allowed mapping the
binding surface in solution [82]. Backbone assignment of domains of
Aha1 and Hsp90 allowed conclusions about the binding interface. The
resulting interaction pattern is consistent with previous crystallo-
graphic data [31]. Remarkably, the data also indicate a possible sec-
ondary binding site on the opposite site of the Aha1 molecule.
A recent study combining NMR and FRET experiments elucidates
the binding mode of Aha1 in full length Hsp90 [82]. Interestingly,
not only the N-terminal but also the C-terminal domain of Aha1
turned out to be involved in interaction with Hsp90. The Buchner
and Kessler groups probed 15N-labelled Hsp90-N and Hsp90-M with
various Aha1 constructs and analysed the chemical shift perturba-
tions [82]. Backbone assignments of Hsp90-N and Hsp90-M allowed
mapping of Hsp90 residues affected by Aha1 binding (Fig. 6). Amino
acids involved in interaction with Aha1 form a large hydrophobic
groove at Hsp90 surface that suggest a possible binding surface
supported by crystallographic data [31]. The N-terminal domain of
Aha1 interacts nucleotide-independent with Hsp90-M, consistent
with previous crystallographic data. Strikingly, the C-terminal domain
of Aha1 interacts with Hsp90-N only in the presence of ATP or an ATP
analogue such as AMP-PNP, suggesting an important role of ATP-
determined Hsp90 conformational rearrangement.
Hsp90 is a symmetric dimer. From a structural point of view, the
Aha1 binding site on the N-terminal and middle domains of Hsp90
would be compatible with symmetric binding of two Aha1 molecules
in a symmetric complex. Interestingly, ATPase assay indicated that
one molecule of Aha1 could already induce maximal stimulation ofATP hydrolysis of the Hsp90 dimer. Aha1 activates the ATPase of
one particular N-terminal domain in both cis- and trans-positions.
The active asymmetric complex consists of one closed Hsp90 dimer
and one Aha1 molecule [82]. This could be crucial for the functional
cycle since binding of a second Aha1 on the other side of the dimer
might interfere with substrate interaction.
8.2. The Hsp90–Cdc37 complex by NMR
Cdc37 is a kinase-speciﬁc co-chaperone. It consists of three domains:
an N-terminal substrate binding domain, a middle Hsp90-binding
domain and C-terminal domain. Cdc37 inhibits Hsp90 ATPase and
traps Hsp90 in an open conformation [84,85]. A crystal structure of
a complex of yeast Hsp90-N and a fragment consisting of the middle
and C-terminal domains of Cdc37 explains that Cdc37 inhibits
Hsp90's ATPase through interaction of the side chain of R167 in
Cdc37's middle domain with the catalytic Glu in Hsp90-N [84].
A complex of Hsp90-N and the middle domain of Cdc37 was
characterised both by NMR chemical perturbation analysis and cross-
saturation transfer experiments that allowed direct mapping of binding
surface between both proteins [86]. The analysis of 1H–15N correlation
spectra of the complex reveals the interaction interface on both sides
of the Hsp90 dimer (Fig. 7). The combination of residual dipolar
couplings, NOE experiments and HADDOCKmodelling provided further
insights into the Hsp90–Cdc37 complex. As a result a detailed structure
of the complexwas built in general similar to the one obtained by X-ray
for yeast Hsp90–Cdc37 [86,87] . The surface area of the NMR-based
structure is distinctly larger (1600 A2) than the one of the crystal struc-
ture (1100 A2) therefore the NMR-based structure is less compact. The
residue Leu205 in Cdc37 is crucial for interaction driving the complex
formation by its hydrophobic nature.
8.3. Hsp90 interaction with p23 by NMR
Similar to Cdc37, the co-chaperone p23 inhibits Hsp90 ATPase.
Some substrates including glucocorticoid and progesterone receptors
are trapped by p23 in a complex with Hsp90 [14,15]. The co-crystal
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dicates that the interaction requires contacts of p23 to both of Hsp90-
N of the dimer as well as both of Hsp90-M [22]. Interestingly, NMR
experiments with constructs comprising N-terminal and/or the mid-
dle domain of Hsp90 revealed that only those fragments containing
Hsp90-M bound to p23 [51]. In contrast, isolated Hsp90-N does not
bind to p23, not even in the presence of nucleotide [51]. This
emphasizes the importance of studying the full-length protein to
understand the mechanism of the Hsp90 machine.
With help of Ile-speciﬁc labelling the sensitivity is sufﬁciently high
to monitor binding of co-chaperones such as p23 to Hsp90 (Fig. 8A).
The determination of the translational diffusion coefﬁcient by 3D
DOSY-TROSY experiments with Ile labelled p23 and unlabelled
Hsp90 demonstrated complex formation of both proteins [74]. Analy-
sis of chemical shift perturbations of 1H–13C spectra of Ile-labelled
full-length Hsp90 in the presence of unlabelled p23 and ATP revealed
an interaction site covering the ATP lid and adjacent regions in both
Hsp90-N and Hsp90-M (Fig. 8B) [55]. The interaction pattern detected
in NMR is in agreement with previous crystallographic data where
binding of p23 to Hsp90-N was demonstrated [22]. Notably, the NMR
spectra of the Hsp90–p23 complex also indicate chemical shifts
corresponding to residues spreading over large parts of Hsp90-M
[55]. Most of those are distant from the crystallographically identi-
ﬁed p23-binding site. In fact, the disordered C-terminus of p23,
which is lacking in the crystal structure, could potentially be respon-
sible for additional contacts to Hsp90-M. Deletion of this stretch still
does not signiﬁcantly modify the chemical shift pattern. Together,
those data indicate that p23 induces long-range conformational
changes in Hsp90-M.
The chemical shift perturbation analysis can also provide some
information on stoichiometry of interaction of Hsp90 upon interac-
tion with co-factors. A subset of Hsp90 peaks shows p23-dependent
doubling of signals (Fig. 8A) [55]. This could be caused by formation
of an asymmetric Hsp902p231 complex, similar to the asymmetric
Hsp902Aha11 [82]. Complementary experiments with native mass
spectrometry demonstrated that human Hsp90 and p23 form aFig. 7. The Cdc37 binding site in Hsp90 maps close to the contact site of both N-
terminal domains in the closed dimer. Residues that shift upon interaction with
Cdc37-M are depicted in red, C-terminal and middle domains of Hsp90 are shown in
blue and green respectively [86].complex with 2:2 stoichiometries. The two p23 may bind to Hsp90
in slightly different mode, which could be responsible for the peak
doubling in the NMR spectra. In this context it is notable that binding
of p23 and Aha1 is mutually exclusive due to a partial overlap on the
interaction interface [22,82]. It will be interesting to ﬁnd out about
conditions that favoured the formation of Hsp902p231Aha11 com-
plexes and whether such a species may play a role in the ATPase
cycle.
It is evident from the structure of the yeast Hsp90–Sba1p23 complex
that the co-chaperone stabilises the ATP-dependent dimerisation of
N-terminal domains [22]. This is consistent with the chemical shift
pattern of the human Hsp90–p23 complex in solution and the NMR
and MS data indicating that the interaction is ATP-dependent [55].
It is not consistent, however, with previous NMR experiments
reporting that p23 binds to Hsp90 in the absence of ATP [51].
This apparent contradiction is most likely related to the different
experimental conditions. The nucleotide independent interaction
was monitored at very low ionic strength (50 mM KCl and 10 mM
Tris pH 6.9). Those conditions favour protein–protein interaction,
particularly at high protein concentrations typically used in NMR.
ATP increases the afﬁnity of p23 for Hsp90 by one order of magnitude,
even at low ionic strength [88]. In turn, high ionic strength conditions
(300 mM NaCl/KCl and 25 mM phosphate pH 7.2) may potentially
suppress the physiologically less relevant ATP-independent interac-
tion even at high protein concentrations in the NMR tube [55]. For
protein concentrations used in most NMR experiments, even physio-
logical ionic strength may support non-physiological associations,
asking for independent veriﬁcation. In case of the Hsp90–p23 interac-
tion NMR conditions at high ionic strength were in pleasing congru-
ence with crystallographic and biochemical data [22,88]. In conclusion,
the role of experimental conditions in investigations of protein com-
plexes can be crucial to avoid unspeciﬁc interactions at the non-
physiologically high protein concentrations of most NMR experiments.
9. Hsp90 interaction with substrates studied by NMR
The key question in understanding the mechanism of the Hsp90
machine is to comprehend its interaction with substrate proteins.
The nature of interaction of Hsp90 with substrates, however, remains
largely elusive. There is only limited knowledge about the folding
state of substrates that interact with the chaperone, the speciﬁcity
of the interaction and the fate of the substrate during the Hsp90
working cycle. Some insights come from an electron microscopic
reconstruction of an Hsp90/Cdc37/Cdk4 complex [29]. The EM pic-
tures indicate an asymmetric complex in which only one substrate
molecule is bound on the outside, possibly making contacts to the
N-terminal and middle domains of Hsp90. So far, however, there is
no high-resolution structure of Hsp90 complexes with bound sub-
strate protein.
The dynamic nature of Hsp90–substrate interactions assigns a
prime role to NMR spectroscopy to study those protein–protein inter-
actions. In addition to the possibility to speciﬁcally monitor a labelled
protein in complex mixtures it provides detailed information on the
conformational state and on protein dynamics. Also, a key advantage
of NMR spectroscopy is the possibility to monitor transient interac-
tions between proteins.
9.1. The structure of the Hsp90-bound substrate protein
Hsp90 suppresses aggregation of proteins in vitro without being
too particular about their whereabouts, whether it is a natural partner
such as p53 or a model protein such as porcine mitochondrial citrate
synthase [7,8,62]. It shows preference for destabilised proteins, such
as for the destabilised viral v-Src kinase versus the constitutive c-Src
or for structural mutants of p53 versus the wild type [62,89].
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interaction of E. coli Hsp90, HtpG, with a partially folded model sub-
strate [32,90]. Speciﬁc structured regions of the 131 aminoacid fragment
of staphylococcal nuclease (Δ131Δ) are supposed to contribute to
binding to HtpG. The interaction occurs via middle domain of HtpG
triggering a structural rearrangement of the chaperone [90]. 1H–15N
cross-peaks of Δ131Δ are non-uniformly affected upon addition of
HtpG. In particular, the subset of signals representing the structured
region decreases in intensity, while the disordered parts are less
affected. The loss of peak intensities is thought to be due to the signal
broadening caused by slow tumbling upon interaction with HtpG
[32].
Such studies with model proteins may give general insights into
the Hsp90–substrate interaction mechanism. Since Hsp90 is thought
to interact with a limited subset of substrates, however, interaction
studies with natural ligands are of particular importance. A particular
attractive target is p53, for which wild type and mutant proteins have
been assayed also with biochemical techniques for Hsp90 interaction
[91–93]. Much of this work is beyond the focus of this review, here
we would like to focus on the NMR data on this topic. The p53 protein
is a homotetrameric transcription factor that is frequently hit by
cancer mutations in its DNA binding core domain [94]. NMR studies
on Hsp90 interaction with the monomeric 25 kDa p53 core domainprovided the most detailed insights of Hsp90 interaction with natural
substrates so far.
9.2. Natural substrates — the p53 case
The NMR analysis on a complex of 15N-labelled DNA binding
core domain of human p53 and non-labelled human full length
Hsp90β revealed that p53 binds to Hsp90 when unfolded [62]. The
complex of Hsp90 and p53 core is around 200 kDa and provides all
the challenges for NMR experiments that are typical for molecules of
this size. The most prominent effect is signal loss due to transverse
relaxation. While the 25 kDa p53 core domain has very good NMR
spectroscopic properties, all the constraints of a large protein com-
plex apply when it binds to the 170 kDa Hsp90 dimer. The p53 core
becomes part of a big complex that has tumbling properties of
around 200 kDa particle, resulting in signal loss due to transverse
relaxation [62].
This signal loss also has advantages, it is an indicator of p53 core
binding to Hsp90, and it allows monitoring even by one dimensional
1H NMR spectroscopy [62]. Interestingly, the signal of folded p53 core
is not affected by the presence of Hsp90. The p53 core protein binds
to Hsp90, however, when the sample is exposed to temperatures
above 36 °C. In the absence of the chaperone, p53 aggregates visibly
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sistent with intrinsic ﬂuorescence data that shows that Hsp90 forms
complexes with p53 wild type and mutant protein upon temperature
increase [62]. Strikingly, destabilised p53 mutants bind to Hsp90
already at lower temperature than wild type does.
The resulting complex can be analysed by CRINEPT–TROSY. In the
absence of Hsp90, the 1H–15N correlation spectra of folded p53 core
are characterised by the complex signal distribution typical for folded
proteins [95]. Upon binding to Hsp90, the spectra are dominated by
signals in the random coil region, including signals that were not
present before in the absence of Hsp90, resulting in a pattern typical
of an unfolded protein [62]. This might not be too surprising given
that p53 was destabilised to force it into a complex with Hsp90.
One could speculate that it might be possible to bind folded p53 to
Hsp90 inducing an unfolded state. In that context it is interesting to
note that under comparable experimental conditions Hsp90 did not
facilitate the exchange of slow-exchanging hydrogens of p53 core
over several days (SGDR, SMV Freund and AR Fersht, unpublished).
Also, Hsp90 does not form a stable complex with the native, wild
type protein in this environment despite the high protein concentra-
tion demanded by the NMR experiment [62].
The p53 protein is not the only example for which Hsp90 binding
leads to destabilising of the protein. Signiﬁcant progress in under-
standing Hsp90–substrate interactions derives from studies on steroid
receptors. During assembly of a complex of Hsp90 and glucocorticoid
receptor, the hydrophobic ligand-binding cleft gets exposed, which
may destabilise the protein. Subsequent binding of steroid within the
cleft triggers a transformation of the receptor and leads to release
from the complex [96]. However, complexes of Hsp90 and steroid re-
ceptors so far escaped a successful analysis by NMR spectroscopy,
which increases the importance of the Hsp90 interaction with p53 core
domain for the deciphering of the substrate recognition mechanism.
The precise nature of p53 when bound to Hsp90 is currently a
subject of a rather exciting mechanistic discussion. A recent NMR
studies on the interaction of the p53 core domain and human Hsp90α
described that this Hsp90 homologue associates with the native
transcription factor [30]. The intensity of cross-peaks in 1H–15N spectra
of p53 core decreases linearly upon addition of Hsp90. Interestingly, this
did not only apply to the full length Hsp90 protein but extended to all
fragments analysed, including Hsp90-N, -M, -NM and -MC. Also, the
isolated middle domain of Hsp90 facilitates the HD exchange of native
p53 core on a short time scale [30]. Nevertheless, signiﬁcant peak shifts
are not observed under these conditions for any of the domains. Given
this complex conformational equilibrium and Hsp90's preference for a
speciﬁc subset of substrates it is remarkable that various monomeric
and dimeric Hsp90 domain constructs lacking a consensus site do not
signiﬁcantly differ in substrate binding properties. Extrinsic ﬂuores-
cence experiments showed an increase of the signal of the dye ANS
upon addition of a fragment lacking the ﬂexible linker between Hsp90-
N and Hsp90-M [30]. The authors concluded that p53 core interacts
reversibly as a molten globule with Hsp90, without forming a stable
complex and lacking a speciﬁc binding motif [30].
A recent study using Hsp90 domain constructs of the yeast homo-
logue demonstrated interaction with folded p53 but came again to
different conclusions [35]. Cross-peaks of p53 core also weaken and
disappear upon titration with any of the Hsp90 domains. However
this effect is speciﬁc to rigid parts and to the binding surface of p53
core and the magnitude of chemical shift differences is consisted
only with minor structural changes. Chemical shift perturbations of
p53 signals upon titration with Hsp90 domain constructs suggest a
speciﬁc binding surface located at DNA-binding interface of p53 core.
9.3. Experimental conditions may inﬂuence p53 binding to Hsp90
At ﬁrst glance, those three studies seem to be contradictory. Those
apparent controversies might disappear when taken a look at theexperimental conditions of those studies. One study uses human
Hsp90β, the other human Hsp90α and the third — p53 titrations
were performed with domain constructs of yeast Hsp90. It would be
an attractive thought that the experimental differences might reﬂect
the functional difference between the homologues. This seems to be
unlikely, however, because such fundamental differences are not
backed up by any functional data. We conclude that the differences
are partly caused by experimental conditions, partly by differences
in interpretation.
One important difference between those studies is ionic strength.
The study involving Hsp90β used 300 mM salt, the studies analysing
Hsp90α and yeast Hsp90 studied interactions at 50–100 mM salt
[30,35,62]. Ionic strength affects protein stability and unspeciﬁc in-
teractions, and both effects account for the reported differences.
This is underlined by a recent study that identiﬁes a charged segment
near the Hsp90 C-terminus as salt-sensitive interaction site [35]. The
major difference between those studies does not relate to the ques-
tion whether unfolded p53 core interacts with Hsp90 but whether
the native p53 core interacts with Hsp90. Wild type p53 core was
previously shown to interact with Hsp90 under low salt conditions
in biochemical binding assays [97]. The high protein concentration
in the NMR experiment may force a substrate protein artiﬁcially
onto the chaperone, which is a well-established drawback of this
method. The co-chaperone p23, for instance, interacts with Hsp90
in low salt in nucleotide independent manner with Hsp90 in NMR
experiments, which is most likely not physiologically relevant
[11,51,55,88]. In high salt conditions, when unspeciﬁc protein–protein
interactions are less favoured, ATP binding becomes essential to
trigger association, even at NMR concentration [55,88]. We assume
that similar effects may play a signiﬁcant role for the Hsp90–p53
interaction.
Crucial for the NMR monitoring of complexes of full length Hsp90
protein with any substrate are the advances in technology. A signif-
icant difference of the Hsp90–p53 studies is the spectroscopic
methodology. The use of CRINEPT–TROSY revealed additional p53
signals in the random coil region when bound to Hsp90 [62]. On
the other hand, HSQC spectra did not allow detecting those signals,
neither for Hsp90α nor Hsp90β [30,62]. Hsp90 is a complex and di-
meric multi-domain protein in which interactions between both of
its halves are crucial for its mechanism. Therefore, studies with
full-length proteins are crucial to take the complex architectural
constraints of the Hsp90 structure into account. While CRINEPT–
TROSY allows detection of Hsp90–substrate complexes now for some
time, future studies may make use of the recent developments using
methyl-speciﬁc labelling techniques as they had been successfully
used for Hsp90 interaction with the co-chaperone p23 [55,62,71,74].
A complication that was not so far taken into account for NMR
studies on Hsp90–p53 is possible nucleotide-dependent effects. ATP-
triggered conformational changes are supposed to be linked to Hsp90
interaction with substrate proteins [3]. A recent biochemical study
analysed the role of ATP for Hsp90 chaperoning of p53 [98]. ATP
binding but not hydrolysis was necessary and sufﬁcient to support
promoter binding of p53. It will be interesting to monitor the effect
of ATP on Hsp90–substrate interactions in future NMR studies.
Another question is to which extent the putative difference be-
tween the molten globule and the unfolded state is in this context
to some extent linguistic differences. In both studies signals in the
β-sheet region disappeared, and both studies agree that they ob-
serve a rather dynamic species [30,62]. Neither of the studies using
full-length Hsp90 and p53 core succeeded in observing signals of
regular secondary structure in the NMR spectra. In turn the spec-
tra involving fragments of yeast Hsp90 found that p53 core signals
disappear due to increased molecular size upon interaction with
Hsp90 domains, while eventual structural changes in p53 were
minor, judged by the minor extent of the detected peak shifts
[35].
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One of the central questions in the ﬁeld is the identiﬁcation of the
substrate-binding site in Hsp90. It is remarkable that despite all the
crystallographic information available for Hsp90 no obvious site had
been identiﬁed [13]. The main reason for this is that the dynamic
nature of the bound client makes co-crystallisation rather challeng-
ing. The EM reconstruction of a complex of the kinase Cdk4 bound
to Hsp90 and Cdc37 revealed interaction of this substrate with both
the N-terminal and middle domains. Similarly, NMR spectroscopy
allowedmapping the binding of the protein Tau to those two domains
in Hsp90 (Rüdiger group, unpublished).
In contrast to those observations, NMR studies of binding of
Hsp90α to p53 core did not identify any speciﬁc binding site [71].
Resonances affected by addition of Hsp90 are spread through the
entire molecule suggesting that the speciﬁcity of Hsp90's interaction
with substrate is not stringently deﬁned in those experiments.
Recent NMR studies on the interaction of domains of yeast Hsp90
with p53 core provide a more complex pattern [35]. Hsp90-C binds to
p53 core with micromolar afﬁnities in a salt-dependent manner. The
responsible binding site is the strongly negatively charged pentapep-
tide motif DEDEE, close to Hsp90's C-terminus. Consequently, NMR
mapping data at low salt identiﬁed a clustering of chemical shift
changes around the disordered C-terminal extension of Hsp90 [35].
NMR mapping data also suggests that the negatively charged DEDEE
motif binds to the positively charged DNA binding cleft of p53 core.
DEDEE is a remarkably simple motif that can be found in several
hundreds of proteins in the human genome. Nevertheless, in an in
vitro aggregation assay, Hsp90 lacking the C-terminal disordered
motif did prevent the precipitation of p53 core less effective than
the wild-type chaperone [35].
Interestingly, the same study succeeded mapping p53 binding to
negatively charged residues on middle domain, in contrast to the
ﬁnding by similar experiments with the middle domain of human
Hsp90α [35,71]. Substitution of those negatively charged amino acids
E415 and E412 by alanine did not affect the ability of the chaperone to
prevent p53 core precipitation in vitro, but the inversion of the charge
had a signiﬁcant effect for the E415K mutant [35].
A key aspect to take into account is related to the fact that one is
studying interactions of a large molecular weight protein with a
potentially dynamic and unstructured partner protein that can lead
to extra experimental differences. The variety in results on Hsp90–
substrate interactions might be caused in part by differences in
Hsp90 homologs and constructs, in part by the experimental differ-
ences. The typically high protein concentrations in NMR experi-
ments favour protein–protein interactions. This effect is ampliﬁed
for samples that have subphysiological ionic strength, which favour
charged interactions. High ionic strength conditions typically stabi-
lise proteins. When interactions of Hsp90 and p53 core are detect-
able at low ionic strength but invisible at high ionic strength, this
could be caused by one of two possible explanations: (i) Low salt
may destabilise p53 core and generate a not fully folded species
that binds to Hsp90, or (ii) p53 core at low ionic strength possibly
in folded form to Hsp90 via ionic interactions.
10. Conclusions and outlook
The interactions observed by structural biology methods includ-
ing NMR spectroscopy provide fundamental information regarding
the protein's functional properties, however these have to be placed
in the big picture of the cell were the chemical environment is differ-
ent from the in vitro condition. Although traditionally an in vitro
method, NMR has moved over the last decade inside living cells
[99,100]. For a few example proteins NMR spectra in human cells
reveal similar pattern as in the test tube, although the dynamics
increase in vivo [101,102]. The complex nature of the Hsp90 machinehas so far prevented similar in-cell NMR experiments. In particular
the role of co-chaperones can be crucial for Hsp90 client recognition
in vivo, as they may possibly trigger so far undetected interaction
mechanisms.
Further structural studies of Hsp90–substrate complexes are re-
quired to elucidate the molecular mechanisms of the recognition of
substrates. NMR spectroscopy will have a key role in this quest due
to its ability to combine high-resolution data with the analysis of
dynamics. Although Hsp90 is a highly challenging protein to study
by NMR spectroscopy a signiﬁcant progress has been made in the
past 10 years. The particular advantage of NMR spectroscopy is the
possibility to analyse dynamic complexes in solution. This is crucial
for the analysis of chaperones with their substrate proteins, which
may not be rigidly folded. Recent progress in selective labelling tech-
niques and spectroscopic techniques allowed overcoming many of
the typical restrictions of NMR spectroscopy. It is particularly impor-
tant that it is now possible to apply this technology to the Hsp90
full-length protein. This is essential to study domain–domain inter-
actions of this dynamic molecular machine. The combination of NMR
experiments with crystallographic and SAXS data will reveal a com-
prehensive picture of Hsp90's molecular mechanism.
Acknowledgements
We are grateful to Ineke Braakman for continuous support, and we
thank Ineke Braakman, Johannes Buchner, Assaf Friedler and Alicja
and Maciej Zylicz for comments on the manuscript. The research of
the Rüdiger group proﬁted from collaboration with Rolf Boelens and
his NMR group at the Bijvoet Center and was supported by a Marie-
Curie Excellence Grant of the EU, a VIDI career development grant
by the Netherlands Organisation for Scientiﬁc Research NWO and a
High Potential Grant of Utrecht University.
References
[1] F.U. Hartl, M. Hayer-Hartl, Converging concepts of protein folding in vitro and in
vivo, Nat. Struct. Mol. Biol. 16 (2009) 574–581.
[2] B. Bukau, J. Weissman, A. Horwich, Molecular chaperones and protein quality
control, Cell 125 (2006) 443–451.
[3] M.P. Mayer, Gymnastics of molecular chaperones, Mol. Cell 39 (2010) 321–331.
[4] K. Richter, J. Buchner, Hsp90: chaperoning signal transduction, J. Cell. Physiol.
188 (2001) 281–290.
[5] J.L. Johnson, C. Brown, Plasticity of the Hsp90 chaperone machine in divergent
eukaryotic organisms, Cell Stress Chaperones 14 (2009) 83–94.
[6] E.A. Nollen, R.I. Morimoto, Chaperoning signaling pathways: molecular chaper-
ones as stress-sensing ‘heat shock’ proteins, J. Cell Sci. 115 (2002) 2809–2816.
[7] U. Jakob, H. Lilie, I. Meyer, J. Buchner, Transient interaction of Hsp90 with early
unfolding intermediates of citrate synthase. Implications for heat shock in vivo,
J. Biol. Chem. 270 (1995) 7288–7294.
[8] H. Wiech, J. Buchner, R. Zimmermann, U. Jakob, Hsp90 chaperones protein folding
in vitro, Nature 358 (1992) 169–170.
[9] D.F. Nathan, S. Lindquist, Mutational analysis of Hsp90 function: interac-
tions with a steroid receptor and a protein kinase, Mol. Cell. Biol. 15 (1995)
3917–3925.
[10] C. Prodromou, B. Panaretou, S. Chohan, G. Siligardi, R. O'Brien, J.E. Ladbury, S.M.
Roe, P.W. Piper, L.H. Pearl, The ATPase cycle of Hsp90 drives a molecular ‘clamp’
via transient dimerization of the N-terminal domains, EMBO J. 19 (2000)
4383–4392.
[11] D.R. Southworth, D.A. Agard, Species-dependent ensembles of conserved confor-
mational states deﬁne the Hsp90 chaperone ATPase cycle, Mol. Cell 32 (2008)
631–640.
[12] K.A. Krukenberg, D.R. Southworth, T.O. Street, D.A. Agard, pH-dependent confor-
mational changes in bacterial Hsp90 reveal a Grp94-like conformation at pH 6
that is highly active in suppression of citrate synthase aggregation, J. Mol. Biol.
390 (2009) 278–291.
[13] L.H. Pearl, C. Prodromou, Structure and mechanism of the hsp90 molecular
chaperone machinery, Annu. Rev. Biochem. 75 (2006) 271–294.
[14] W.B. Pratt, D.O. Toft, Steroid receptor interactions with heat shock protein and
immunophilin chaperones, Endocr. Rev. 18 (1997) 306–360.
[15] H. Kosano, B. Stensgard, M.C. Charlesworth, N. McMahon, D. Toft, The assembly
of progesterone receptor–hsp90 complexes using puriﬁed proteins, J. Biol.
Chem. 273 (1998) 32973–32979.
[16] S.J.H. Arlander, S.J. Felts, J.M. Wagner, B. Stensgard, D.O. Toft, L.M. Karnitz,
Chaperoning checkpoint kinase 1 (Chk1), an Hsp90 client, with puriﬁed chaper-
ones, J. Biol. Chem. 281 (2006) 2989–2998.
646 T. Didenko et al. / Biochimica et Biophysica Acta 1823 (2012) 636–647[17] L.H. Pearl, C. Prodromou, P. Workman, The Hsp90 molecular chaperone: an open
and shut case for treatment, Biochem. J. 410 (2008) 439–453.
[18] B.C. Freeman, D.O. Toft, R.I. Morimoto, Molecular chaperone machines: chaper-
one activities of the cyclophilin Cyp-40 and the steroid aporeceptor-associated
protein p23, Science (New York, N Y) 274 (1996) 1718–1720.
[19] R. Zhao,M. Davey, Y.C. Hsu, P. Kaplanek, A. Tong, A.B. Parsons, N. Krogan, G. Cagney,
D. Mai, J. Greenblatt, C. Boone, A. Emili, W.A. Houry, Navigating the chaperone
network: an integrative map of physical and genetic interactions mediated by
the hsp90 chaperone, Cell 120 (2005) 715–727.
[20] C. Prodromou, S.M. Roe, R. O'Brien, J.E. Ladbury, P.W. Piper, L.H. Pearl, Identiﬁ-
cation and structural characterization of the ATP/ADP-binding site in the Hsp90
molecular chaperone, Cell 90 (1997) 65–75.
[21] S.H. McLaughlin, H.W. Smith, S.E. Jackson, Stimulation of the weak ATPase activ-
ity of human hsp90 by a client protein, J. Mol. Biol. 315 (2002) 787–798.
[22] M.M.U. Ali, S.M. Roe, C.K. Vaughan, P. Meyer, B. Panaretou, P.W. Piper, C. Prodromou,
L.H. Pearl, Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone
complex, Nature 440; 7087 (2006) 1013–1017.
[23] W.M. Obermann, H. Sondermann, A.A. Russo, N.P. Pavletich, F.U. Hartl, In vivo
function of Hsp90 is dependent on ATP binding and ATP hydrolysis, J. Cell Biol.
143 (1998) 901–910.
[24] L.H. Pearl, Hsp90 and Cdc37— a chaperone cancer conspiracy, Curr. Opin. Genet.
Dev. 15 (2005) 55–61.
[25] M. Zhang, M. Boter, K. Li, Y. Kadota, B. Panaretou, C. Prodromou, K. Shirasu, L.H.
Pearl, Structural and functional coupling of Hsp90- and Sgt1-centred multi-
protein complexes, EMBO J. 27 (2008) 2789–2798.
[26] C. Prodromou, S.M. Roe, P.W. Piper, L.H. Pearl, A molecular clamp in the crystal
structure of the N-terminal domain of the yeast Hsp90 chaperone, Nat. Struct.
Biol. 4 (1997) 477–482.
[27] J.C. Young, C. Schneider, F.U. Hartl, In vitro evidence that hsp90 contains two
independent chaperone sites, FEBS Lett. 418 (1997) 139–143.
[28] T. Scheibel, T. Weikl, J. Buchner, Two chaperone sites in Hsp90 differing in sub-
strate speciﬁcity and ATP dependence, Proc. Natl. Acad. Sci. U. S. A. 95 (1998)
1495–1499.
[29] C.K. Vaughan, U. Gohlke, F. Sobott, V.M. Good,M.M. Ali, C. Prodromou, C.V. Robinson,
H.R. Saibil, L.H. Pearl, Structure of an Hsp90–Cdc37–Cdk4 complex, Mol. Cell 23
(2006) 697–707.
[30] S.J. Park, B.N. Borin, M.A. Martinez-Yamout, H.J. Dyson, The client protein p53
adopts a molten globule-like state in the presence of Hsp90, Nat. Struct. Mol.
Biol. 18 (2011) 537–541.
[31] P. Meyer, C. Prodromou, C. Liao, B. Hu, S. Mark Roe, C.K. Vaughan, I. Vlasic, B.
Panaretou, P.W. Piper, L.H. Pearl, Structural basis for recruitment of the
ATPase activator Aha1 to the Hsp90 chaperone machinery, EMBO J. 23
(2004) 511–519.
[32] T.O. Street, L.A. Lavery, D.A. Agard, Substrate binding drives large-scale conforma-
tional changes in the Hsp90 molecular chaperone, Mol. Cell 42 (2011) 96–105.
[33] P. Meyer, C. Prodromou, B. Hu, C. Vaughan, S.M. Roe, B. Panaretou, P.W. Piper,
L.H. Pearl, Structural and functional analysis of the middle segment of hsp90:
implications for ATP hydrolysis and client protein and cochaperone interactions,
Mol. Cell 11 (2003) 647–658.
[34] S.F. Harris, A.K. Shiau, D.A. Agard, The crystal structure of the carboxy-terminal
dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential sub-
strate binding site, Structure (Camb) 12 (2004) 1087–1097.
[35] F. Hagn, S. Lagleder, M. Retzlaff, J. Rohrberg, O. Demmer, K. Richter, J. Buchner, H.
Kessler, Structural analysis of the interaction between Hsp90 and the tumor
suppressor protein p53, Nat. Struct. Mol. Biol. (2011) 1–8.
[36] G. Morra, M.A.C. Neves, C.J. Plescia, S. Tsustsumi, L. Neckers, G. Verkhivker, D.C.
Altieri, G. Colombo, Dynamics-based discovery of allosteric inhibitors: selection
of new ligands for the C-terminal domain of Hsp90, J. Chem. Theory Comput. 6
(2010) 2978–2989.
[37] C. Garnier, D. Laﬁtte, P.O. Tsvetkov, P. Barbier, J. Leclerc-Devin, J.M.Millot, C. Briand,
A.A. Makarov, M.G. Catelli, V. Peyrot, Binding of ATP to heat shock protein 90:
evidence for an ATP-binding site in the C-terminal domain, J. Biol. Chem. 277
(2002) 12208–12214.
[38] J. Frydman, J. Höhfeld, Chaperones get in touch: the Hip-Hop connection, Trends
Biochem. Sci. 22 (1997) 87–92.
[39] C.A. Ballinger, P. Connell, Y. Wu, Z. Hu, L.J. Thompson, L.Y. Yin, C. Patterson, Iden-
tiﬁcation of CHIP, a novel tetratricopeptide repeat-containing protein that inter-
acts with heat shock proteins and negatively regulates chaperone functions,
Mol. Cell. Biol. 19 (1999) 4535–4545.
[40] M. Zhang, M. Windheim, S.M. Roe, M. Peggie, P. Cohen, C. Prodromou, L.H. Pearl,
Chaperoned ubiquitylation–crystal structures of the CHIP U box E3 ubiquitin
ligase and a CHIP-Ubc13-Uev1a complex, Mol. Cell 20 (2005) 525–538.
[41] C. Scheuﬂer, A. Brinker, G. Bourenkov, S. Pegoraro, L. Moroder, H. Bartunik, F.U.
Hartl, I. Moareﬁ, Structure of TPR domain-peptide complexes: critical elements
in the assembly of the Hsp70-Hsp90 multichaperone machine, Cell 101 (2000)
199–210.
[42] O. Hainzl, M.C. Lapina, J. Buchner, K. Richter, The charged linker region is an
important regulator of Hsp90 function, J. Biol. Chem. 284 (2009) 22559–22567.
[43] A.K. Shiau, S.F. Harris, D.R. Southworth, D.A. Agard, Structural analysis of E. coli
hsp90 reveals dramatic nucleotide-dependent conformational rearrangements,
Cell 127 (2006) 329–340.
[44] D.E. Dollins, J.J. Warren, R.M. Immormino, D.T. Gewirth, Structures of GRP94–
nucleotide complexes reveal mechanistic differences between the hsp90
chaperones, Mol. Cell 28 (2007) 41–56.
[45] K.A. Krukenberg, T.O. Street, L.A. Lavery, D.A. Agard, Conformational dynamics of
the molecular chaperone Hsp90, Q. Rev. Biophys. 44 (2011) 229–255.[46] C. Ratzke, M. Mickler, B. Hellenkamp, J. Buchner, T. Hugel, Dynamics of heat
shock protein 90 C-terminal dimerization is an important part of its conforma-
tional cycle, Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 16101–16106.
[47] K. Wüthrich, NMR studies of structure and function of biological macromole-
cules (Nobel lecture), Angew. Chem. Int. Ed. Engl. 42 (2003) 3340–3363.
[48] D.M. Jacobs, T. Langer, B. Elshorst, K. Saxena, K.M. Fiebig, M. Vogtherr, H.
Schwalbe, NMR backbone assignment of the N-terminal domain of human
HSP90, J. Biomol. NMR 36 (Suppl. 1) (2006) 52.
[49] A. Dehner, J. Furrer, K. Richter, I. Schuster, J. Buchner, H. Kessler, NMR chemical
shift perturbation study of the N-terminal domain of Hsp90 upon binding of
ADP, AMP-PNP, geldanamycin, and radicicol, Chembiochem 4 (2003) 870–877.
[50] R.M. Salek, M.A. Williams, C. Prodromou, L.H. Pearl, J.E. Ladbury, Backbone reso-
nance assignments of the 25kD N-terminal ATPase domain from the Hsp90
chaperone, J. Biomol. NMR 23 (2002) 327–328.
[51] M.A. Martinez-Yamout, R.P. Venkitakrishnan, N.E. Preece, G. Kroon, P.E. Wright,
H.J. Dyson, Localization of sites of interaction between p23 and Hsp90 in solution,
J. Biol. Chem. 281 (2006) 14457–14464.
[52] P. Workman, Combinatorial attack on multistep oncogenesis by inhibiting the
Hsp90 molecular chaperone, Cancer Lett. 206 (2004) 149–157.
[53] T. Zhang, A. Hamza, X. Cao, B. Wang, S. Yu, C.G. Zhan, D. Sun, A novel Hsp90
inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells,
Mol. Cancer Ther. 7 (2008) 162–170.
[54] M.G. Marcu, A. Chadli, I. Bouhouche, M. Catelli, L.M. Neckers, The heat shock
protein 90 antagonist novobiocin interacts with a previously unrecognized
ATP-binding domain in the carboxyl terminus of the chaperone, J. Biol. Chem.
275 (2000) 37181–37186.
[55] G.E. Karagöz, A.M. Duarte, H. Ippel, C. Uetrecht, T. Sinnige, M. van Rosmalen, J.
Hausmann, A.J. Heck, R. Boelens, S.G.D. Rüdiger, N-terminal domain of human
Hsp90 triggers binding to the cochaperone p23, Proc. Natl. Acad. Sci. U. S. A. 108
(2011) 580–585.
[56] J. Cavanagh, W.J. Fairbrother, A.G.I. Palmer, N.J. Skelton, M. Rance, Protein NMR
Spectroscopy. Principles and Practice, Academic Press, London, 2006.
[57] R. Riek, K. Pervushin, K. Wüthrich, TROSY and CRINEPT: NMR with large molec-
ular and supramolecular structures in solution, Trends Biochem. Sci. 25 (2000)
462–468.
[58] K. Pervushin, R. Riek, G. Wider, K. Wüthrich, Attenuated T2 relaxation by mutual
cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an
avenue to NMR structures of very large biological macromolecules in solution,
Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 12366–12371.
[59] E.B. Bertelsen, L. Chang, J.E. Gestwicki, E.R. Zuiderweg, Solution conformation of
wild-type E. coli Hsp70 (DnaK) chaperone complexed with ADP and substrate,
Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 8471–8476.
[60] M. Revington, Y. Zhang, G.N. Yip, A.V. Kurochkin, E.R. Zuiderweg, NMR investi-
gations of allosteric processes in a two-domain Thermus thermophilus Hsp70
molecular chaperone, J. Mol. Biol. 349 (2005) 163–183.
[61] J. Fiaux, E.B. Bertelsen, A.L. Horwich, K. Wüthrich, NMR analysis of a 900K GroEL
GroES complex, Nature 418 (2002) 207–211.
[62] S. Rüdiger, S.M. Freund, D.B. Veprintsev, A.R. Fersht, CRINEPT–TROSY NMR
reveals p53 core domain bound in an unfolded form to the chaperone Hsp90,
Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11085–11090.
[63] G.E. Karagöz, T. Sinnige, O. Hsieh, S.G.D. Rüdiger, Expressed protein ligation for a
large dimeric protein, Protein Eng. Des. Sel. 24 (2011) 495–501.
[64] V. Tugarinov, L.E. Kay, Ile, Leu, and Val methyl assignments of the 723-residue
malate synthase G using a new labeling strategy and novel NMR methods, J.
Am. Chem. Soc. 125 (2003) 13868–13878.
[65] V. Tugarinov, P.M. Hwang, J.E. Ollerenshaw, L.E. Kay, Cross-correlated relaxation
enhanced1H–13CNMRspectroscopy ofmethyl groups in veryhighmolecularweight
proteins and protein complexes, J. Am. Chem. Soc. 125 (2003) 10420–10428.
[66] V. Tugarinov, L.E. Kay, Relaxation rates of degenerate 1H transitions in methyl
groups of proteins as reporters of side-chain dynamics, J. Am. Chem. Soc. 128
(2006) 7299–7308.
[67] V. Tugarinov, L.E. Kay, An isotope labeling strategy for methyl TROSY spectroscopy,
J. Biomol. NMR 28 (2004) 165–172.
[68] T.L. Religa, R. Sprangers, L.E. Kay, Dynamic regulation of archaeal proteasome
gate opening as studied by TROSY NMR, Science 328 (2010) 98–102.
[69] R. Sprangers, L.E. Kay, Quantitative dynamics and binding studies of the 20S
proteasome by NMR, Nature 445 (2007) 618–622.
[70] I. Gelis, A.M. Bonvin, D. Keramisanou, M. Koukaki, G. Gouridis, S. Karamanou,
A. Economou, C.G. Kalodimos, Structural basis for signal-sequence recogni-
tion by the translocase motor SecA as determined by NMR, Cell 131 (2007)
756–769.
[71] S.J. Park, M. Kostic, H.J. Dyson, Dynamic interaction of Hsp90 with its client
protein p53, J. Mol. Biol. 411 (2011) 158–173.
[72] A. Velyvis, H.K. Schachman, L.E. Kay, Assignment of Ile, Leu, and Val methyl cor-
relations in supra-molecular systems: an application to aspartate transcarba-
moylase, J. Am. Chem. Soc. 131 (2009) 16534–16543.
[73] C.S. Johnson Jr., Diffusion ordered nuclear magnetic resonance spectroscopy:
principles and applications, Prog. Nucl. Magn. Reson. Spectrosc. 34 (1999) 203–256.
[74] T. Didenko, R. Boelens, S.G.D. Rüdiger, 3D DOSY–TROSY to determine the trans-
lational diffusion coefﬁcient of large protein complexes, Protein Eng. Des. Sel. 24
(2011) 99–103.
[75] M.P. Mayer, C. Prodromou, J. Frydman, The Hsp90 mosaic: a picture emerges,
Nat. Struct. Mol. Biol. 16 (2009) 2–6.
[76] K. Richter, S. Walter, J. Buchner, The co-chaperone Sba1 connects the ATPase
reaction of Hsp90 to the progression of the chaperone cycle, J. Mol. Biol. 342
(2004) 1403–1413.
647T. Didenko et al. / Biochimica et Biophysica Acta 1823 (2012) 636–647[77] G. Siligardi, B. Hu, B. Panaretou, P.W. Piper, L.H. Pearl, C. Prodromou, Co-chaperone
regulation of conformational switching in the Hsp90 ATPase cycle, J. Biol. Chem.
279 (2004) 51989–51998.
[78] K. Richter, P. Muschler, O. Hainzl, J. Reinstein, J. Buchner, Sti1 is a non-
competitive inhibitor of the Hsp90 ATPase. Binding prevents the N-terminal
dimerization reaction during the atpase cycle, J. Biol. Chem. 278 (2003)
10328–10333.
[79] B. Panaretou, G. Siligardi, P. Meyer, A. Maloney, J.K. Sullivan, S. Singh, S.H.
Millson, P.A. Clarke, S. Naaby-Hansen, R. Stein, R. Cramer, M. Mollapour, P.
Workman, P.W. Piper, L.H. Pearl, C. Prodromou, Activation of the ATPase activity
of hsp90 by the stress-regulated cochaperone aha1, Mol. Cell 10 (2002)
1307–1318.
[80] J.L. Holmes, S.Y. Sharp, S. Hobbs, P. Workman, Silencing of HSP90 cochaperone
AHA1 expression decreases client protein activation and increases cellular
sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin,
Cancer Res. 68 (2008) 1188–1197.
[81] X. Wang, J. Venable, P. LaPointe, D.M. Hutt, A.V. Koulov, J. Coppinger, C. Gurkan,
W. Kellner, J. Matteson, H. Plutner, J.R. Riordan, J.W. Kelly, J.R. Yates III, W.E.
Balch, Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in
cystic ﬁbrosis, Cell 127 (2006) 803–815.
[82] M. Retzlaff, F. Hagn, L. Mitschke, M. Hessling, F. Gugel, H. Kessler, K. Richter, J.
Buchner, Asymmetric activation of the hsp90 dimer by its cochaperone aha1,
Mol. Cell 37 (2010) 344–354.
[83] H.J. Dyson, M. Kostic, J. Liu, M.A. Martinez-Yamout, Hydrogen-deuterium
exchange strategy for delineation of contact sites in protein complexes, FEBS
Lett. 582 (2008) 1495–1500.
[84] W. Zhang, M. Hirshberg, S.H. McLaughlin, G.A. Lazar, J.G. Grossmann, P.R.
Nielsen, F. Sobott, C.V. Robinson, S.E. Jackson, E.D. Laue, Biochemical and struc-
tural studies of the interaction of Cdc37 with Hsp90, J. Mol. Biol. 340 (2004)
891–907.
[85] N. Grammatikakis, J.H. Lin, A. Grammatikakis, P.N. Tsichlis, B.H. Cochran,
p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function, Mol.
Cell. Biol. 19 (1999) 1661–1672.
[86] S. Sreeramulu, H.R. Jonker, T. Langer, C. Richter, C.R. Lancaster, H. Schwalbe, The
human Cdc37.Hsp90 complex studied by heteronuclear NMR spectroscopy, J.
Biol. Chem. 284 (2009) 3885–3896.
[87] S.M. Roe, M.M. Ali, P. Meyer, C.K. Vaughan, B. Panaretou, P.W. Piper, C. Prodromou,
L.H. Pearl, The mechanism of Hsp90 regulation by the protein kinase-speciﬁc co
chaperone p50(cdc37), Cell 116 (2004) 87–98.
[88] S.H. McLaughlin, F. Sobott, Z.P. Yao, W. Zhang, P.R. Nielsen, J.G. Grossmann, E.D.
Laue, C.V. Robinson, S.E. Jackson, The co-chaperone p23 arrests the Hsp90
ATPase cycle to trap client proteins, J. Mol. Biol. 356 (2006) 746–758.[89] M. Taipale, D.F. Jarosz, S. Lindquist, HSP90 at the hub of protein homeostasis:
emerging mechanistic insights, Nat. Rev. Mol. Cell Biol. 11 (2010) 515–528.
[90] T.O. Street, L.A. Lavery, K. Verba, C. Lee, M.P. Mayer, D.A. Agard, Cross-Monomer
Substrate Contacts Reposition the Hsp90 N-Terminal Domain and Prime the
Chaperone Activity, J. Mol. Biol. (in press).
[91] F.W. King, A. Wawrzynow, J. Höhfeld, M. Zylicz, Co-chaperones Bag-1, Hop and
Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53,
EMBO J. 20 (2001) 6297–6305.
[92] M. Zylicz, F.W. King, A. Wawrzynow, Hsp70 interactions with the p53 tumour
suppressor protein, EMBO J. 20 (2001) 4634–4638.
[93] D. Walerych, M.B. Olszewski, M. Gutkowska, A. Helwak, M. Zylicz, A. Zylicz,
Hsp70 molecular chaperones are required to support p53 tumor suppressor
activity under stress conditions, Oncogene 28 (2009) 4284–4294.
[94] A.N. Bullock, A.R. Fersht, Rescuing the function of mutant p53, Nat. Rev. Cancer 1
(2001) 68–76.
[95] K.B.Wong, B.S. DeDecker, S.M. Freund, M.R. Proctor,M. Bycroft, A.R. Fersht, Hot-spot
mutants of p53 core domain evince characteristic local structural changes, Proc. Natl.
Acad. Sci. U. S. A. 96 (1999) 8438–8442.
[96] W.B. Pratt, D.O. Toft, Regulation of signaling protein function and trafﬁcking by
the hsp90/hsp70-based chaperone machinery, Exp. Biol. Med. (Maywood) 228
(2003) 111–133.
[97] L. Müller, A. Schaupp, D. Walerych, H. Wegele, J. Buchner, Hsp90 regulates the
activity of wild type p53 under physiological and elevated temperatures, J.
Biol. Chem. 279 (2004) 48846–48854.
[98] D. Walerych, M. Gutkowska, M.P. Klejman, B. Wawrzynow, Z. Tracz, M. Wiech,
M. Zylicz, A. Zylicz, ATP binding to Hsp90 is sufﬁcient for effective chaperoning
of p53 protein, J. Biol. Chem. 285 (2010) 32020–32028.
[99] Z. Serber, P. Selenko, R. Hansel, S. Reckel, F. Lohr, J.E. Ferrell Jr., G. Wagner, V.
Dötsch, Investigating macromolecules inside cultured and injected cells by in-cell
NMR spectroscopy, Nat. Protoc. 1 (2006) 2701–2709.
[100] M.M. Dedmon, C.N. Patel, G.B. Young, G.J. Pielak, FlgM gains structure in living
cells, Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 12681–12684.
[101] D. Sakakibara, A. Sasaki, T. Ikeya, J. Hamatsu, T. Hanashima, M. Mishima, M.
Yoshimasu, N. Hayashi, T. Mikawa, M. Walchli, B.O. Smith, M. Shirakawa, P.
Guntert, Y. Ito, Protein structure determination in living cells by in-cell NMR
spectroscopy, Nature 458 (2009) 102–105.
[102] K. Inomata, A. Ohno, H. Tochio, S. Isogai, T. Tenno, I. Nakase, T. Takeuchi, S.
Futaki, Y. Ito, H. Hiroaki, M. Shirakawa, High-resolution multi-dimensional
NMR spectroscopy of proteins in human cells, Nature 458 (2009) 106–109.
[103] D. Jacobs, T. Langer, B. Elshorst, K. Saxena, K. Fiebig, M. Vogtherr, H. Schwalbe,
NMR Backbone Assignment of the N-terminal Domain of Human HSP90, J.
Biomol. NMR 36 (2006) 52-52.
